Company Analysis

Maravai LifeSciences Holdings, Inc. (MRVI)

Nasdaq: MRVI · Pharmaceutical Preparations · San Diego, CA · filing with the SEC since 2020
Grade3.8
◀ Past 3.9● Present 4.4▶ Future 2.9

Who runs Maravai LifeSciences Holdings, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Brust Bernd
Chief Executive Officer. First filing Jun 2025, latest Nov 12, 2026, 2 filings in all.
Officers reporting now
4
of 11 people with a filing in the last fifteen months
Directors reporting now
7
33 people on the record since 2020
Officerssales are open-market, Nov 12, 2025 to Nov 12, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Brust BerndChief Executive OfficerJun 2025Nov 12, 2026none
Asarpota RajeshChief Financial OfficerJun 2025Nov 2, 2026none
Oreshack KurtGeneral CounselNov 2020Jun 10, 20262 · $300,000
Dolan ChristineExecutive Vice President & General Manager, Cygnus TechnologiesNov 2020May 22, 2026none
Directorssales are open-market, Nov 12, 2025 to Nov 12, 2026
NameRoleFirst filingLatest filingSales, 12 months
Lucier Gregory TdirectorNov 2020Jun 10, 2026none
Cunningham Sean LaurencedirectorNov 2020May 28, 2026none
Deford John AdirectorJul 2023May 28, 2026none
Eckert R AndrewdirectorDec 2024May 28, 2026none
Gray SusannahdirectorNov 2020May 28, 2026none
Marker Luke JosephdirectorNov 2020May 28, 2026none
Mihas Constantine SdirectorNov 2020May 28, 2026none
Earlier names on the record22, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton MRVI · research, not advice